America
U.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss Products
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas.